DeepMed Research

INSTITUTE OF LIVER AND BILIARY SCIENCES

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Fecal Microbiota Therapy in Steroid Ineligible Alcoholic Hepatitis

Not Applicable

Conditions: Alcoholic Hepatitis

Interventions: Drug: Standard Medical Treatment
Other: Fecal Transplantation

First Posted Date: 2022-03-17

Last Posted Date: 2022-04-20

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 84

Registration Number: NCT05285592

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Impact of Teach Back of Discharge Information in Term of Patient Recall of Information and Patient Engagement

Not Applicable

Completed

Conditions: Patient Engagement

Interventions: Other: Teach back
Other: Standard of care

First Posted Date: 2022-03-15

Last Posted Date: 2022-04-01

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT05280171

Locations: 🇮🇳
Sheetal Chhikara, New Delhi, Delhi, India

Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy

Not Applicable

Conditions: Hepatic Encephalopathy

Interventions: Other: Standard Medical Treatment
Other: Fecal Microbiota Transplant

First Posted Date: 2022-02-08

Last Posted Date: 2022-02-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 66

Registration Number: NCT05229289

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Effectiveness of Teaching Program for the Management of Upper GI Bleeding

Completed

Conditions: Nurse

First Posted Date: 2022-01-26

Last Posted Date: 2022-03-31

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 20

Registration Number: NCT05207410

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

Not Applicable

Recruiting

Conditions: Non-cirrhotic, Chronic Hepatitis B

Interventions: Drug: Tenofovir alafenamide fumarate

First Posted Date: 2022-01-19

Last Posted Date: 2022-02-28

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 200

Registration Number: NCT05195450

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.

Not Applicable

Conditions: Liver Cirrhosis

Interventions: Drug: Simvastatin 40mg
Other: Placebo
Other: Standard medical Treatment

First Posted Date: 2022-01-12

Last Posted Date: 2022-03-15

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 45

Registration Number: NCT05187715

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.

Not Applicable

Recruiting

Conditions: Acute on Chronic Liver Failure

Interventions: Drug: Carvedilol 12.5 MG

First Posted Date: 2022-01-06

Last Posted Date: 2022-01-11

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 50

Registration Number: NCT05180292

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease

Completed

Conditions: Liver Diseases

Interventions: Other: This is an observational study

First Posted Date: 2021-12-22

Last Posted Date: 2022-01-04

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 1316

Registration Number: NCT05167305

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Comparative Efficacy of Various Non-invasive Methods in Assessing Response to Beta-blockers as Secondary Prophylaxis for Acute Variceal Bleed.

Conditions: Acute Variceal Bleed

Interventions: Other: This is an observational study

First Posted Date: 2021-12-21

Last Posted Date: 2022-01-14

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 200

Registration Number: NCT05166317

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

To Compare "Balloon Occluded Thrombolysis" With "Conventional Catheter Directed Thrombolysis" in Thrombotically Occluded DIPSS Stent in Patients of Budd- Chiari Syndrome.

Completed

Conditions: Budd-Chiari Syndrome

Interventions: Procedure: Novel
Procedure: Conventional

First Posted Date: 2021-11-11

Last Posted Date: 2021-12-27

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 33

Registration Number: NCT05117684

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy